Main Menu

Tuesday, September 23rd, 2025

 

The Second Chu Culture Festival Opens in Jingzhou, China

On the evening of September 20, the opening ceremony of the Second Chu Culture Festival was held in Jingzhou, China. The event was guided by the China Public Diplomacy Association, the China Federation of Cultural Promotion, and the Cultural Communication Committee of the China Cultural Management Association, hosted by the CPC Jingzhou Municipal Committee and the Jingzhou Municipal People’s Government, and organized by Hubei Radio and Television Station. Cultural scholars from home and abroad, diplomats from multiple countries stationed in China, international youth representatives, elite Chu entrepreneurs, figures from theRead More


Zeagoo’s 12th Anniversary Grand Collaboration with Maye Musk: Early Autumn Fashion Guide First Release

As early autumn arrives, the global women’s apparel brand Zeagoo celebrates its 12th Anniversary. Since its founding, Zeagoo has always stood by “Be Different, Be You,’”upholding its mission to create comfortable and fashionable apparel for mature women. It aims to convey a brand philosophy of easy, comfortable self-expression and self-realization. At this landmark moment, Zeagoo officially announces September 22nd as its 12th Anniversary celebration day. This celebration is highlighted by the launch of the “Zeagoo X Maye Musk’”2025 Early Autumn Zeagoo Fall Style Guide, a collaboration with the internationally renownedRead More


China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies

China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies   SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the “Agreements”) with Chongqing Genrix Biopharmaceutical Co., Ltd. (“Genrix Bio”) for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, “Vecantoxatug”) indicated for passive immunization against tetanus and Silevimig Injection (GR1801, “Silevimig”) indicated for passive immunizationRead More